Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
// David Vindrieux 1,2,3,4 , Guillaume Devailly 1,2,3,4 , Arnaud Augert 1,2,3,4 , Benjamin Le Calvé 1,2,3,4 , Mylène Ferrand 1,2,3,4 , Pascal Pigny 5,6 , Léa Payen 1,2,3,4 , Gérard Lambeau 7 , Michael Perrais 5 , Sébastien Aubert 5,8 , Hélène Simonnet 1,2,3,4 , Robert Dante 1,2,3,4 and David Bernard 1,2,3,4 1 Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France; 2 CNRS UMR5286, Lyon France; 3 Centre Léon Bérard, Lyon, France; 4 Université de Lyon, Lyon, France; 5 INSERM U837, Jean-Pierre Aubert Research Center, Lille, France; 6 Institut de Biochimie et Biologie Moléculaire Centre de Biologie Pathologie CHRU Lille, Lille, France; 7 Institut de Pharmacologie Moléculaire et Cellulaire, UMR6097, CNRS and Université de Nice-Sophia Antipolis, Valbonne, France; 8 Institut de Pathologie, CHRU, Faculté de Médecine, Université de Lille, Lille, France. Correspondence: David Bernard, email: // Keywords : VHL; MYC; HIF; PLA2R1; tumor suppressor Received : December 11, 2013 Accepted : January 16, 2014 Published : January 16, 2014 Abstract Loss of secreted phospholipase A2 receptor (PLA2R1) has recently been found to render human primary cells more resistant to senescence whereas increased PLA2R1 expression is able to induce cell cycle arrest, cancer cell death or blockage of cancer cell transformation in vitro, suggesting that PLA2R1 displays tumor suppressive activities. Here we report that PLA2R1 expression strongly decreases in samples of human renal cell carcinoma (RCC). Knockdown of PLA2R1 increases renal cancer cell tumorigenicity supporting a role of PLA2R1 loss to promote in vivo RCC growth. Most RCC result from Von Hippel-Lindau (VHL) tumor suppressor loss-of-function and subsequent gain-of-function of the oncogenic HIF-2alpha/c-MYC pathway. Here, by genetically manipulating VHL, HIF-2alpha and c-MYC, we demonstrate that loss of VHL, stabilization of HIF-2alpha and subsequent increased c-MYC activity, binding and transcriptional repression, through induction of PLA2R1 DNA methylation closed to PLA2R1 transcriptional start site, results in decreased PLA2R1 transcription. Our results describe for the first time an oncogenic pathway leading to PLA2R1 transcriptional repression and the importance of this repression for tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
Beck, L. H., Bonegio, R. G. B., Lambeau, G., Beck, D. M., Powell, D. W., Cummins, T. D., Klein, J. B., & Salant, D. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810457 · Cited by 2,347
Self-citationHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“We have previously discovered that in normal human cells, loss of the phospholipase A2 receptor (PLA2R1) delays senescence or favors senescence escape, depending on the stress [6, 7], senescence being a tumor suppressive pathway [8-13].”
Vaziri, H., & Benchimol, S. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70109-5 · Cited by 1,003 · cited 1×
“We have previously discovered that in normal human cells, loss of the phospholipase A2 receptor (PLA2R1) delays senescence or favors senescence escape, depending on the stress [6, 7], senescence being a tumor suppressive pathway [8-13].”
Therapy-induced senescence in cancer.
Ewald, J. A., Desotelle, J. A., Wilding, G., & Jarrard, D. F. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq364 · Cited by 824
HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity
Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.006 · Cited by 781
HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma
Gordan, J. D., Lal, P., Dondeti, V. R., Letrero, R., Parekh, K. N., Oquendo, C. E., Greenberg, R. A., Flaherty, K. T., Rathmell, W. K., Keith, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.016 · Cited by 493 · cited 2×
“HIF2α exerts its oncogenic activity by increasing c-MYC transcriptional activities, the activating as well as the repressing ones [28, 29].”
Pro-senescence therapy for cancer treatment
Nardella, C., Clohessy, J. G., Alimonti, A., & Pandolfi, P. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3057 · Cited by 437
Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326 · cited 1×
“We have previously discovered that in normal human cells, loss of the phospholipase A2 receptor (PLA2R1) delays senescence or favors senescence escape, depending on the stress [6, 7], senescence being a tumor suppressive pathway [8-13].”
Yan, Q., Bartz, S., Mao, M., Li, L., & Kaelin, W. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01514-06 · Cited by 193 · cited 2×
“To determine whether HIFα protein degradation is involved in VHL-induced PLA2R1 transcription, we examined PLA2R1 transcript levels in ACHN (Figure 4D), RCC10+VHL (Figure 4E), and 786-O+VHL cells (Figure 4F) constitutively synthesizing a non-degradable form of either HIF1α or HIF2α [20].”
Cited by
Cellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150
Secreted phospholipases A2 in cancer: Diverse mechanisms of action
Brglez, V., Lambeau, G., & Petan, T. (2014) · Biochimie · doi:10.1016/j.biochi.2014.09.023 · Cited by 89
Self-citationWang, Y., Chen, S., Yan, Z., & Pei, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0264-9 · Cited by 56
Metadata
- Authors
- Vindrieux, D., Devailly, G., Augert, A., Le Calvé, B., Ferrand, M., Pigny, P., Payen, L., Lambeau, G., Perrais, M., Aubert, S., Simonnet, H., Dante, R., & Bernard, D.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-01-16
- Volume
- 5
- Issue
- 4
- Pages
- 1004-1013
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1900137947
- Cited by
- 42
- References
- 11
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.